HOME
거래/파트너링/M&A

Otsuka, Jnana Therapeutics 인수: 8억 달러 선불, 최대 11억 달러 거래

Company
Otsuka Pharmaceuticals, Jnana Therapeutics
Category
거래/파트너링/M&A
Drug (API)
JNT-517
Indication
Phenylketonuria (PKU)
Release Date
2024/08/05
TA
Rare Diseases
Type
M&A
Approval DB
Class
Clinical DB
Licensing DB
Licensing DB (1) (Article DB)에 관계됨
Partnership DB
Target
Upload Date
2 more properties

한글종합기사

Official Announcement
BioPharma Dive
BioSpace
Firstword
Fierce Group